Secondary Intelligence™ が、オフターゲット活性や潜在的な有害事象を予測することで、化合物評価をどのように支援できるかをご覧ください。Join Claire Clare Gilmer PhD as she introduces the latest ToxStudio® software features:

1. Visualize secondary pharmacology data

2. Compare test compound coverage with drugs targeting specific receptors

3. Predict safety outcomes in both in vivo and clinical settings

Enhance decision-making while optimizing drug safety and efficacy with Secondary Intelligence™. Watch now.